Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas

This study has been completed.
Sponsor:
Collaborators:
Isis Pharmaceuticals
Information provided by:
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00005594
First received: May 2, 2000
Last updated: December 30, 2010
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2000 (Final data collection date for primary outcome measure)